GenMark Diagnostics Appoints Scott Mendel Chief Financial Officer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GenMark Diagnostics, Inc. (Nasdaq:GNMK) announced today that it has named Scott Mendel as Chief Financial Officer, effective May 13, 2014.

Mendel brings 25 years of public company financial leadership experience and a proven track record of leading highly-complex, global businesses. Mendel joins GenMark from Active Network, where he served for nearly four years as its Chief Financial Officer and provided financial leadership through their IPO, global restructuring, and subsequent sale to Vista Equity.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC